BioVaria is designed for dealmakers and investors from the global life-science sector responsible for identifying, licensing or funding break-through innovations. In just one interactive day, it showcases around 50 licensable life-science technologies and spin-offs originating from publicly funded research.
// BioVaria presents cutting-edge IP assets and spin-offs originating from Europe’s leading life-science institutions. It is a unique opportunity to discover high-potential investment opportunities and connect with innovative minds across Europe. // Dr Peter Neubeck, TVM Capital
Don’t miss the BioVaria 2015 Spin-off Panel
This year’s BioVaria will again feature an interactive afternoon with a number of truly interesting and fresh European start-ups:
- Guided by Tobias Rodehau, Partner of Pinsent Masons, the spin-off programme will begin with an interactive session during which the companies will briefly pitch their businesses and face a challenging Q&A session
- Investors will then have the opportunity to get to know the entrepreneurs during a face-to-face ‘Speed Dating’ at the ‘Spin-off Corner’ and an additional hour for meeting-and-mingling
- The conclusion of the programme will be the ‘BioVaria Spin-off Awards’ ceremony featuring an overall value of EUR 3,000
Preview BioVaria’s Technologies and Spin-offs online
- Explore the technologies presented in 10-min oral presentations and posters
- Get a first impression of the participating start-ups
Register now at www.biovaria.org
Who should attend?
- Scouts and business developers from the international biopharmaceutical industry looking for cutting-edge inventions to complement their companies’ R&D portfolios
- Life-science investors looking for attractive spin-offs or IP assets as investment opportunities
- Technology transfer professionals and scientists from public research institutions who have patent-protected technologies available for licensing or partnering
Patron:
Bavarian Ministry of Economic Affairs and Media, Energy and Technology
Sponsors:
BioM, Boehringer Ingelheim, Johnson & Johnson Innovation, MSD, HERTIN, LSP, Vossius & Partner
Spin-off Panel Sponsor:
Pinsent Masons
Regional Supporter:
IFB - Intercollegiate Faculty of Biotechnology/University of Gdansk, TVM Capital
Communication sponsor:
Business Wire, Current Partnering, GoingPublic, KONOCOM, transkript
Technology transfer partners: Aalborg University, Ascenion, Austria Wirtschaftsservice Gesellschaft, Bayerische Patentallianz, Bio&Technology Innovations Platform, BTO - Bergen Teknologioverføring, CIBICAN, EMBLEM Technology Transfer, FIST, Helmholtz Zentrum München, IOCB TTO, Lead Discovery Center, Max-Planck-Innovation, MITO Technology, MRC Technology, PROvendis
Network partner:
ASTP Proton, Bayern Innovativ, BIO Deutschland, Best of X, TTS Global Initiative
